24,99 €
inkl. MwSt.

Versandfertig in 1-2 Wochen
payback
12 °P sammeln
  • Broschiertes Buch

The book,"Tissue Engineering: Changing paradigm", is a book with focus on understanding of basics in Tissue regeneration techniques and processes with examples on recent technology and product development. Tissue Engineering has grown frog leap over the last decade and has evolved with an approach towards Regenerative Medicine and Human therapeutics. The book addresses issues and biological concepts based on engineering and technology. The chapters of the book focus on cartilage and bone tissue engineering and wound healing concepts and products. Emphasis is on use of bioreactors for cell…mehr

Produktbeschreibung
The book,"Tissue Engineering: Changing paradigm", is a book with focus on understanding of basics in Tissue regeneration techniques and processes with examples on recent technology and product development. Tissue Engineering has grown frog leap over the last decade and has evolved with an approach towards Regenerative Medicine and Human therapeutics. The book addresses issues and biological concepts based on engineering and technology. The chapters of the book focus on cartilage and bone tissue engineering and wound healing concepts and products. Emphasis is on use of bioreactors for cell culture, design and evaluation of scaffolds for tissue regeneration and development of contemporary products as therapeutic substitutes. The book also focuses on Upscale of the technology towards development of regenerative products.The book would be useful for the researchers and scientists who are trying to develop various products and processes in the field of tissue regeneration.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dr Srivastava, a Professor at the School of Biochemical Engineering, IIT (BHU), Varanasi, India, has an impressive track record of more than 10 years of experience in Industries and 13 years of Teaching and Research. He has authored several Books, Chapters, Papers and has more than a dozen patents. He is advisor to several biotechnology companies.